NovaBridge Biosciences (NBP) — Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

NovaBridge Biosciences (NBP) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of $13.15 Million represents 1% of operating cash flow ($13.15 Million). See NBP working capital efficiency to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$13.15 Million
USD

Operating Cash Flow

$13.15 Million
USD

Capital Expenditures

$41.00
USD

NovaBridge Biosciences Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for NovaBridge Biosciences across 1 annual periods. Explore NovaBridge Biosciences (NBP) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for NovaBridge Biosciences (2020–2020)

Year-by-year Free Cash Flow Generation Index for NovaBridge Biosciences. For the full company profile including market capitalisation, see NBP stock market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2020 0.98x $425.55 Million $433.56 Million $8.01 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).